Shunjiang Yu - Shanghai Pharmaceuticals Chief Officer
| 601607 Stock | 19.25 0.02 0.10% |
Executive
Shunjiang Yu is Chief Officer of Shanghai Pharmaceuticals Holding
| Phone | 86 21 6373 0908 |
| Web | https://www.sphchina.com |
Shanghai Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of 0.0241 % which means that it generated a profit of $0.0241 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0641 %, meaning that it generated $0.0641 on every $100 dollars invested by stockholders. Shanghai Pharmaceuticals' management efficiency ratios could be used to measure how well Shanghai Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Hua Lin | Bank of Communications | 57 | |
| Hong Tu | Bank of Communications | 59 | |
| Jianjun Liu | Bank of Communications | N/A | |
| Xiao Ye | Beijing Kaiwen Education | 44 | |
| Jiangtao She | Jiangsu Phoenix Publishing | 61 | |
| Zhao Wu | Bank of Communications | 70 | |
| Zhaobin CPA | Bank of Communications | 56 | |
| Yuan Du | Eastern Communications Co | 46 | |
| Zhu Yichen | Bank of Communications | N/A | |
| Tao Yang | Bank of Communications | N/A | |
| Ge Zhu | Eastern Communications Co | 49 | |
| Zong Yang | Duzhe Publishing Media | 42 | |
| Shujun Li | Duzhe Publishing Media | 57 | |
| Min Chen | Jiangsu Phoenix Publishing | 53 | |
| Bin Qian | Bank of Communications | 52 | |
| Yan Wang | Eastern Communications Co | N/A | |
| Guohua Jin | Jiangsu Phoenix Publishing | 60 | |
| Chen Yu | Bank of Communications | N/A | |
| Gang Guan | Beijing Kaiwen Education | 44 | |
| Linyan Yang | Shanghai Action Education | 49 | |
| Xiao Hu | Jiangsu Phoenix Publishing | 54 | |
Management Performance
| Return On Equity | 0.0641 | |||
| Return On Asset | 0.0241 |
Shanghai Pharmaceuticals Leadership Team
Elected by the shareholders, the Shanghai Pharmaceuticals' board of directors comprises two types of representatives: Shanghai Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shanghai. The board's role is to monitor Shanghai Pharmaceuticals' management team and ensure that shareholders' interests are well served. Shanghai Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shanghai Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shuai Shao, Vice President | ||
| Qiuhua Yang, Executive Chairman | ||
| Ying Ke, Director Center | ||
| Tao Zhong, Board VP | ||
| Man Cho, Pres Director | ||
| Shunjiang Yu, Chief Officer | ||
| Bo CPA, CFO and Presidentident | ||
| Ming Dong, Executive Director | ||
| Dongming Li, Vice President | ||
| Yongzhong Li, VP Director | ||
| Jinqi Yu, G Mang | ||
| Shui ACS, Joint Secretary | ||
| Pui Wong, Joint Secretary | ||
| Bo Shen, CFO, President | ||
| Linqiong Dong, Securities Representative |
Shanghai Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Shanghai Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0641 | |||
| Return On Asset | 0.0241 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 71.64 B | |||
| Shares Outstanding | 2.79 B | |||
| Shares Owned By Insiders | 64.98 % | |||
| Shares Owned By Institutions | 12.78 % | |||
| Price To Book | 1.01 X | |||
| Price To Sales | 0.24 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Shanghai Stock
Shanghai Pharmaceuticals financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Pharmaceuticals security.